Anavex Life Sciences (FRA:12X1) FCF Yield % : -10.38 (As of Apr. 28, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Anavex Life Sciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Anavex Life Sciences's Trailing 12-Month Free Cash Flow is €-27.19 Mil, and Market Cap is €263.31 Mil. Therefore, Anavex Life Sciences's FCF Yield % for today is -10.38%.

The historical rank and industry rank for Anavex Life Sciences's FCF Yield % or its related term are showing as below:

FRA:12X1' s FCF Yield % Range Over the Past 10 Years
Min: -10.53 Med: 0 Max: 0
Current: -10.38

FRA:12X1's FCF Yield % is ranked better than
58.45% of 1550 companies
in the Biotechnology industry
Industry Median: -15.535 vs FRA:12X1: -10.38

Anavex Life Sciences's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Anavex Life Sciences FCF Yield % Historical Data

The historical data trend for Anavex Life Sciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anavex Life Sciences FCF Yield % Chart

Anavex Life Sciences Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

FCF Yield %

Get a 7-Day Free Trial

-10.65

-7.39

-2.24

-3.14

-5.00

Anavex Life Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-3.30	-5.27	-4.78	-4.21	-3.82

Competitive Comparison of Anavex Life Sciences's FCF Yield %

For the Biotechnology subindustry, Anavex Life Sciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anavex Life Sciences's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anavex Life Sciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Anavex Life Sciences's FCF Yield % falls into.

Anavex Life Sciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Anavex Life Sciences's FCF Yield % for the fiscal year that ended in Sep. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-26.035	/	520.794009
	=	-5.00%

Anavex Life Sciences's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-6.711	*	4	/	702.332094
	=	-3.82%

Anavex Life Sciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Anavex Life Sciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of Anavex Life Sciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Anavex Life Sciences (FRA:12X1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anavex Life Sciences Corp (FRA:12X1) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

AVXL:USA

Address

630 5th Avenue, 20th Floor, New York, NY, USA, 10111

Website

https://www.anavex.com

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

Anavex Life Sciences (FRA:12X1) Headlines

No Headlines